Best Place to Get SYNAPSE Blend Online: How to Choose a Provider, and What Pepti Offers

A physician reviews your history and writes a prescription in your name, and a state-licensed pharmacy prepares the vial to that prescription under sterile-compounding standards. The label carries your name, the product, the strength of each component, your directions, the pharmacy and a beyond-use date. This is the only lawful route to SYNAPSE for your own use, explained in are peptides legal in the US.

These are sold as laboratory chemicals with a "not for human consumption" disclaimer. There is no prescriber, no pharmacist and no one to report a reaction to. For a blend there is an extra problem: you are trusting a seller's word on four separate amounts, and one purity percentage cannot speak for all four. Tesamorelin adds another: it is a 44-amino-acid peptide, and a research listing gives you no way to know whether what is in the vial matches it. The full comparison is in research peptides vs prescription peptides.

Listings often use a cognitive-sounding name for whatever mix they sell. SYNAPSE means these four peptides in these amounts, and the proportions matter: tesamorelin and MOTS-c are 20 of the 30 mg in the vial, so by mass it is two-thirds a metabolic preparation with two smaller neuropeptide components. Its relatives on the same site are Semax + Selank, the brain-only pair, and ELEVATE, which keeps Semax and Selank and adds BPC-157 and KPV. A legitimate provider names every component in milligrams and millilitres.

A valid prescription from a physician licensed where you live is the first test. You can check any physician through your state medical board's public license lookup, as described in how to check an online peptide doctor is licensed. A provider that approves everyone instantly is not reviewing anyone. A real review sometimes says no, and at Pepti being declined is refunded.

For SYNAPSE specifically, a good intake asks about existing psychiatric treatment, since Selank is described as modifying GABA signalling; about diabetes or impaired glucose tolerance, because tesamorelin can worsen glucose tolerance; about any personal history of cancer and about pregnancy, because the approved tesamorelin product is contraindicated in active malignancy and in pregnancy; about pituitary conditions and corticosteroid replacement; and about tested sport. It should also ask whether you have a diagnosed condition such as ADHD, an anxiety disorder, depression or mild cognitive impairment, because those have established treatments that SYNAPSE is not a substitute for. A provider that asks none of this is not looking at the blend you are about to inject.

Ask which pharmacy fills the prescription and where it is licensed. Every state board of pharmacy publishes a license lookup. Pepti's medications are compounded by PCAB-accredited, FDA-registered US 503A compounding pharmacies, and the dispensing pharmacy's name is on your label. FDA registration is a real, checkable status, and it is not FDA approval.

A certificate of analysis should name the laboratory, the lot, the methods and the date, and for an injectable it should cover sterility and bacterial endotoxin, not only a purity figure. Pepti publishes lot results at lab results, and how to read a certificate of analysis explains each line.

Compare the monthly total, not the headline. Ask whether the price includes physician review, the pharmacy, syringes and cold-chain shipping. Pepti's SYNAPSE price is one figure: $279 a month for medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. The breakdown is on what SYNAPSE costs, and general pricing factors are in how much do peptides cost.

This is where "nootropic" sellers most often give themselves away. SYNAPSE has never been studied as a combination. Semax has Russian clinical work in ischaemic stroke patients by the intranasal route, and no randomised trial for attention in healthy adults. Selank has Russian comparator trials in diagnosed anxiety disorders, also intranasal. MOTS-c has no human trials of any kind. Tesamorelin has the strongest human evidence: the phase 3 visceral-fat trials behind the approved product, and one 20-week 2012 trial in adults aged 55 to 87 that reported a favourable effect on a cognitive composite at 1 mg nightly, with the authors calling for longer trials. That trial is of tesamorelin alone, at twice the dose a SYNAPSE injection contains, in older adults. A provider that says SYNAPSE improves memory or focus is describing something nobody has measured.

Semax, Selank and MOTS-c were placed in Category 2 of the FDA's 503A list in 2023 and none sits in any active category now. In July 2026 the advisory committee voted to recommend adding Semax (8 to 5) and MOTS-c (7 to 5) to the 503A Bulks List, with the FDA's determinations pending; Selank has never been reviewed. Tesamorelin is the active ingredient of an FDA-approved product and is compounded off-label. A provider should be able to say that accurately, and should never call compounded SYNAPSE "FDA approved."